Zolpidem in Parkinson's disease

The safety and tolerability of zolpidem--an update.

Journal of psychopharmacology (Oxford, England)·1999

Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study.

The Journal of international medical research·1998

The effect of intravenous phenylephrine on airway calibre in asthma.

The European respiratory journal·1995

Assessment of the severity of asthma by an expert system. Description and evaluation.

American journal of respiratory and critical care medicine·1995

[Pulmonary lymphangiomyomatosis. Long-term benefit of anti-estrogen treatments remains uncertain].

Revue de pneumologie clinique·1995

Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.

The Journal of pharmacology and experimental therapeutics·1992

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Psoriasis.

Lancet (London, England)·2026

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2026

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Lancet (London, England)·2026

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

Lancet (London, England)·2026

PAI-1 As a Therapeutic Target: A State-of-the-Art Review.

Seminars in thrombosis and hemostasis·2026

Beyond mood: the neurobiological rationale for using SSRIs and SNRIs in the care of inflammatory bowel disease and disorders of gut-brain interaction.

Minerva gastroenterology·2026

Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.

Health expectations : an international journal of public participation in health care and health policy·2026

Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

The Journal of rheumatology·2026

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

EULAR rheumatology open·2026

Onset of Motor Complications and Medication Dose in Newly Diagnosed and Treated Parkinson's Disease.

Parkinson's disease·2026

Related Experiment Videos

Zolpidem in Parkinson's disease

Related Concept Videos

The safety and tolerability of zolpidem--an update.

Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study.

The effect of intravenous phenylephrine on airway calibre in asthma.

Assessment of the severity of asthma by an expert system. Description and evaluation.

[Pulmonary lymphangiomyomatosis. Long-term benefit of anti-estrogen treatments remains uncertain].

Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Psoriasis.

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

PAI-1 As a Therapeutic Target: A State-of-the-Art Review.

Beyond mood: the neurobiological rationale for using SSRIs and SNRIs in the care of inflammatory bowel disease and disorders of gut-brain interaction.

Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.

Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

Onset of Motor Complications and Medication Dose in Newly Diagnosed and Treated Parkinson's Disease.

Related Experiment Videos

Zolpidem in Parkinson's disease

Related Concept Videos

Related Articles